CMS has proposed a policy to close what it says is a loophole that could help drugmakers avoid Medicare negotiations by making small changes to their existing drugs.

Trump administration revisits policy to plug Medicare drug price negotiation loophole.

CMS has proposed a policy to close what it says is a loophole that could help drugmakers avoid Medicare negotiations by making small changes to their existing drugs.